Related Experiment Video
Updated: May 25, 2025

Morphology Control for Fully Printable Organic–Inorganic Bulk-heterojunction Solar Cells Based on a Ti-alkoxide and Semiconducting Polymer
Published on: January 10, 2017
Optimizing β-Phase Content in PVDF Membranes via Modification of Dope Solution with Citric Acid/Nano-TiO2 Using
Md Nahid Parvez Roni1, Tanvir Ahmed Neshath1, Md Azizul Hakim1
1Department of Chemistry, University of Rajshahi, Rajshahi 6205, Bangladesh.
Abstract:
The morphology of Poly (vinylidene fluoride) (PVDF) membranes prepared via the nonsolvent-induced phase separation (NIPS) method was modulated by altering the dope solution with citric acid (CA) and titanium dioxide nanoparticles (nano-TiO2) to optimize the β-phase content. Three series of dope solutions were prepared in dimethyl acetamide (DMAc): (i) TONx series contained 0.0-10% citric acid, (ii) Mx series contained 0.0-0.4% nano-TiO2, and (iii) TAx series contained 5% CA and 0.0-0.40% nano-TiO2. A field emission scanning electron microscopy (FESEM) study revealed that CA enhances pore opening, and nano-TiO2 transforms the sponge-like uneven porous structures into a compact, relatively regular honeycomb structure in the PVDF membranes. The combined effect of CA and nano-TiO2 in the dope solution made the channels and chambers of the membrane well organized, and the walls of the channels transformed from solid fibrils to cross-woven nanofiber-like entities. Porosity initially peaked at 84% in the TAx series, gradually decreasing to 72% with increasing nano-TiO2 concentrations. X-ray diffraction (XRD), Fourier-Transformed Infrared Spectroscopy (FTIR), and Differential Scanning Calorimetry (DSC) revealed the presence of a combined relative amount of the β- and γ-polymorphs of 84% in a neat PVDF membrane, 88% in an Mx, and 96% in a TAx series membrane, with the β-PVDF constituting nearly the entire portion of the combined polymorphs. The presence of 96% electroactive polymorph content in the PVDF membrane is noteworthy, highlighting its potential biomedical and industrial applications.

